AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2025
Oct 15, 2025
31676_dirs_2025-10-14_bb33a7fe-72a9-4ddf-81a6-ed05d0a557d7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2025-10-13
Reporting Person: Cook Meredith (SR. VP, GENERAL COUNSEL & SEC.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-10-13 | Common Stock | S | 400 | $90.09 | Disposed | 75674 | Direct |
Footnotes
F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 17, 2024.
More from ANI PHARMACEUTICALS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Report Publication Announcement
2026
May 13
Interim / Quarterly Report
2026
May 8
Report Publication Announcement
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Investor Presentation
2026
Mar 3